Piscitelli SC - Search Results

1

Effect of atazanavir and atazanavir/ritonavir on the pharmacokinetics of the next-generation HIV integrase inhibitor, S/GSK1349572.

Song I, Borland J, Chen S, Lou Y, Peppercorn A, Wajima T, Min S, Piscitelli SC. Song I, et al. Among authors: piscitelli sc. Br J Clin Pharmacol. 2011 Jul;72(1):103-8. doi: 10.1111/j.1365-2125.2011.03947.x. Br J Clin Pharmacol. 2011. PMID: 21342217 Free PMC article. Clinical Trial.

2

Pharmacokinetics, safety, and monotherapy antiviral activity of GSK1265744, an HIV integrase strand transfer inhibitor.

Spreen W, Min S, Ford SL, Chen S, Lou Y, Bomar M, St Clair M, Piscitelli S, Fujiwara T. Spreen W, et al. HIV Clin Trials. 2013 Sep-Oct;14(5):192-203. doi: 10.1310/hct1405-192. HIV Clin Trials. 2013. PMID: 24144896 Clinical Trial.

3

Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor.

Piscitelli S, Kim J, Gould E, Lou Y, White S, de Serres M, Johnson M, Zhou XJ, Pietropaolo K, Mayers D. Piscitelli S, et al. Br J Clin Pharmacol. 2012 Aug;74(2):336-45. doi: 10.1111/j.1365-2125.2012.04194.x. Br J Clin Pharmacol. 2012. PMID: 22288567 Free PMC article. Clinical Trial.

4

Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients.

Zhang J, Hayes S, Sadler BM, Minto I, Brandt J, Piscitelli S, Min S, Song IH. Zhang J, et al. Br J Clin Pharmacol. 2015 Sep;80(3):502-14. doi: 10.1111/bcp.12639. Epub 2015 Jul 14. Br J Clin Pharmacol. 2015. PMID: 25819132 Free PMC article.

5

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults.

Min S, Sloan L, DeJesus E, Hawkins T, McCurdy L, Song I, Stroder R, Chen S, Underwood M, Fujiwara T, Piscitelli S, Lalezari J. Min S, et al. AIDS. 2011 Sep 10;25(14):1737-45. doi: 10.1097/QAD.0b013e32834a1dd9. AIDS. 2011. PMID: 21716073 Clinical Trial.

6

Effects of etravirine on the pharmacokinetics of the integrase inhibitor S/GSK1265744.

Ford SL, Gould E, Chen S, Lou Y, Dumont E, Spreen W, Piscitelli S. Ford SL, et al. Antimicrob Agents Chemother. 2013 Jan;57(1):277-80. doi: 10.1128/AAC.01685-12. Epub 2012 Oct 31. Antimicrob Agents Chemother. 2013. PMID: 23114768 Free PMC article. Clinical Trial.

7

Effect of prednisone on the pharmacokinetics of the integrase inhibitor dolutegravir.

Song IH, Borland J, Chen S, Savina P, Peppercorn AF, Piscitelli S. Song IH, et al. Antimicrob Agents Chemother. 2013 Sep;57(9):4394-7. doi: 10.1128/AAC.00728-13. Epub 2013 Jul 1. Antimicrob Agents Chemother. 2013. PMID: 23817375 Free PMC article. Clinical Trial.

8

Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects.

Song I, Mark S, Chen S, Savina P, Wajima T, Peppercorn A, Bala U, Geoffroy P, Piscitelli S. Song I, et al. Drug Alcohol Depend. 2013 Dec 1;133(2):781-4. doi: 10.1016/j.drugalcdep.2013.08.009. Epub 2013 Aug 26. Drug Alcohol Depend. 2013. PMID: 24018316 Free article. Clinical Trial.

9

Relative bioavailability of a paediatric granule formulation of the HIV integrase inhibitor dolutegravir in healthy adult subjects.

Patel P, Song I, Borland J, Chen S, Peppercorn A, Wajima T, Funaki T, Fujita N, Hughes J, Piscitelli S. Patel P, et al. Antivir Ther. 2014;19(3):229-33. doi: 10.3851/IMP2708. Epub 2013 Nov 25. Antivir Ther. 2014. PMID: 24275098 Clinical Trial.

10

Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics.

Chen S, St Jean P, Borland J, Song I, Yeo AJ, Piscitelli S, Rubio JP. Chen S, et al. Pharmacogenomics. 2014 Jan;15(1):9-16. doi: 10.2217/pgs.13.190. Pharmacogenomics. 2014. PMID: 24329186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters